PLCB4 and melanoma: In exceedingly difficult cases, molecular and genomic analysis can also be beneficial, as melanoma arising in blue nevi do not typically exhibit BRAF mutations, but rather GNAQ, GNA11, PLCB4, or CYSLTR2 mutations [23,24].